sexta-feira, 13 de novembro de 2026
PesquisarExplore
Source trace. Via News points to the documents behind its reporting and shows what we drew from each — so you can check any claim. How we source
Source document· December 9, 2025

‘All Airlines Are Poised to Bounce’: Citi Makes the Case for Buying These 2 Airline Stocks Now

View original at finance.yahoo.com
‘All Airlines Are Poised to Bounce’: Citi Makes the Case for Buying These 2 Airline Stocks Now The airline industry struggled over the past year, with multiple headwinds weighing on demand…
Opening lines of the source · short snapshot — read the full document at the original

O que extraímos desta fonte

The claims Via News extracted from this document. We point to the source; we don't replace it.

  • Legacy low-cost carriers will be relative underperformers through the cycle

    80% confidence
  • Risks of structural impairment at American Airlines are overstated; if AAL demonstrates company-specific momentum, stock offers most significant upside potential among supermajors

    80% confidence
  • Alaska Air is most supermajor-like of non-supermajor carriers and management strategy leans toward developing supermajor strengths

    80% confidence
  • Alaska Air rated Buy with $61 price target representing 23% upside potential

    80% confidence
  • Supermajors will be biggest beneficiaries through the airline industry cycle with most favorable risk/reward

    80% confidence
  • Alaska Air's Accelerate target of >$10/share in EPS in 2027 is still possible despite consensus backing away

    80% confidence
  • American Airlines rated Buy with $19 price target representing 28% upside potential

    80% confidence
  • Recent pullback in Alaska Air shares creates unusual opportunity to build long-term position at near tactical lows

    80% confidence
  • All airlines are poised to bounce with positive setup for elongated mid-cycle beginning in 2026

    80% confidence
O que sabemos · a inteligência por trás desta página
Ao vivo do substrato
O que estamos a ver
Late-2026 Biotech Catalyst Season: FDA Decisions and Pivotal Readouts Converge Across Oncology, Hepatology and Cardiometabolic
Mid-November 2026 is dense with scheduled biotech catalysts. The ivonescimab BLA PDUFA date is 2026-11-14, the lorundrostat PDUFA date is 2026-12-22, and Phase 3 ECLIPSE hepatitis delta data are due in Q1 2027. Alongside these, siRNA and antibody programs (plozasiran, elebsiran/tobevibart, ianalumab, nipocalimab) reported or presented data at AHA, AASLD, ACR and ASH, while Oryzon advanced iadademstat in AML with Spanish trial authorizations and a planned ALICE-3 Phase III. Late-stage data and regulatory milestones are driving the sentiment. A planned delisting (EGM 2026-11-19, application 2027-01-25) is a separate corporate-structure event with no clear link to the rest.
A nossa leitura dos dados ›
Sinais que acompanhamos
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Padrões que observamos ›
Onde as fontes divergem
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
Sinalizamos conflitos abertamente ›
Verificado recentemente
✓ Verificado com a fonte original
4,995
factos rastreados à sua fonte — e sinalizamos os que não se confirmam.
101 entidades acompanhadas4,995 factos verificados com a fonte5,577 documentos-fonte arquivados
Consulte estes dados → isubstrate.com
‘All Airlines Are Poised to Bounce’: Citi Makes the Case for Buying These 2 Airline Stocks Now — Source | Via News | pt.VIA.NEWS